Literature DB >> 25296012

Infection with murine norovirus 4 does not alter Helicobacter-induced inflammatory bowel disease in Il10(-/-) mice.

Charlie C Hsu1, Jisun Paik2, Piper M Treuting2, Audrey Seamons2, Stacey M Meeker2, Thea L Brabb2, Lillian Maggio-Price2.   

Abstract

Infection of laboratory mice with murine noroviruses (MNV) is widely prevalent. MNV alters various mouse models of disease, including the Helicobacter bilis-induced mouse model of inflammatory bowel disease (IBD) in Mdr1a(--) mice. To further characterize the effect of MNV on IBD, we used mice deficient in the immunoregulatory cytokine IL10 (Il10(-/-) mice). In vitro infection of Il10(-/-) bone marrow-derived macrophages (BMDM) with MNV4 cocultured with H. bilis antigens increased the gene expression of the proinflammatory cytokines IL1β, IL6, and TNFα as compared with that of BMDM cultured with H. bilis antigens only. Therefore, to test the hypothesis that MNV4 infection increases inflammation and alters disease phenotype in H. bilis-infected Il10(-/-) mice, we compared the amount and extent of inflammation in Il10(-/-) mice coinfected with H. bilis and MNV4 with those of mice singly infected with H. bilis. IBD scores, incidence of IBD, or frequency of severe IBD did not differ between mice coinfected with H. bilis and MNV4 and those singly infected with H. bilis. Mice infected with MNV4 only had no appreciable IBD, comparable to uninfected mice. Our findings suggest that, unlike in Mdr1a(-/-) mice, the presence of MNV4 in Il10(-/-) mouse colonies is unlikely to affect the IBD phenotype in a Helicobacter-induced model. However, because MNV4 altered cytokine expression in vitro, our results highlight the importance of determining the potential influence of MNV on mouse models of inflammatory disease, given that MNV has a tropism for macrophages and dendritic cells and that infection is widely prevalent.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25296012      PMCID: PMC4170090     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  56 in total

Review 1.  Towards a molecular risk map--recent advances on the etiology of inflammatory bowel disease.

Authors:  Philip Rosenstiel; Christian Sina; Andre Franke; Stefan Schreiber
Journal:  Semin Immunol       Date:  2009-11-17       Impact factor: 11.130

Review 2.  Recent insights into microbial triggers of interleukin-10 production in the host and the impact on infectious disease pathogenesis.

Authors:  Benjamin L Duell; Chee K Tan; Alison J Carey; Fan Wu; Allan W Cripps; Glen C Ulett
Journal:  FEMS Immunol Med Microbiol       Date:  2012-02-14

3.  Transient or persistent norovirus infection does not alter the pathology of Salmonella typhimurium induced intestinal inflammation and fibrosis in mice.

Authors:  Peter D R Higgins; Laura A Johnson; Kay Sauder; David Moons; Luz Blanco; Stefan Taube; Christiane E Wobus
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2011-01-14       Impact factor: 2.268

4.  Natural colonization with Helicobacter species and the development of inflammatory bowel disease in interleukin-10-deficient mice.

Authors:  Li Zhang; Stephen J Danon; Martin Grehan; Vivian Chan; Adrian Lee; Hazel Mitchell
Journal:  Helicobacter       Date:  2005-06       Impact factor: 5.753

5.  Murine norovirus increases atherosclerotic lesion size and macrophages in Ldlr(-/-) mice.

Authors:  Jisun Paik; Yvette Fierce; Phuong-Oanh Mai; Susan R Phelps; Thomas McDonald; Piper Treuting; Rolf Drivdahl; Thea Brabb; Renee LeBoeuf; Kevin D O'Brien; Lillian Maggio-Price
Journal:  Comp Med       Date:  2011-08       Impact factor: 0.982

6.  Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice.

Authors:  A Burich; R Hershberg; K Waggie; W Zeng; T Brabb; G Westrich; J L Viney; L Maggio-Price
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-09       Impact factor: 4.052

7.  Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice.

Authors:  Maciej Chichlowski; Julie M Sharp; Deborah A Vanderford; Matthew H Myles; Laura P Hale
Journal:  Comp Med       Date:  2008-12       Impact factor: 0.982

8.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

9.  Antibody is critical for the clearance of murine norovirus infection.

Authors:  Karen A Chachu; David W Strong; Anna D LoBue; Christiane E Wobus; Ralph S Baric; Herbert W Virgin
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

Review 10.  T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade.

Authors:  Dmitry V Ostanin; Jianxiong Bao; Iurii Koboziev; Laura Gray; Sherry A Robinson-Jackson; Melissa Kosloski-Davidson; V Hugh Price; Matthew B Grisham
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-25       Impact factor: 4.052

View more
  12 in total

1.  Murine Norovirus Infection Variably Alters Atherosclerosis in Mice Lacking Apolipoprotein E.

Authors:  Charlie C Hsu; Jisun Paik; Thea L Brabb; Kevin D O'Brien; Jinkyu Kim; Brittany G Sullivan; Kelly L Hudkins; Audrey Seamons; Jennifer C Finley; Stacey M Meeker; Lillian Maggio-Price
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

2.  Lack of Effect of Murine Norovirus Infection on the CD4+ CD45RBhigh T-cell Adoptive Transfer Mouse Model of Inflammatory Bowel Disease.

Authors:  Charlie C Hsu; Karuna Patil; Audrey Seamons; Thea L Brabb; Piper M Treuting; Jisun Paik; Stacey M Meeker; Lillian Maggio-Price
Journal:  Comp Med       Date:  2020-01-14       Impact factor: 0.982

Review 3.  Norovirus Regulation by Host and Microbe.

Authors:  Megan T Baldridge; Holly Turula; Christiane E Wobus
Journal:  Trends Mol Med       Date:  2016-11-22       Impact factor: 11.951

4.  Obstructive Lymphangitis Precedes Colitis in Murine Norovirus-Infected Stat1-Deficient Mice.

Authors:  Audrey Seamons; Piper M Treuting; Stacey Meeker; Charlie Hsu; Jisun Paik; Thea Brabb; Sabine S Escobar; Jonathan S Alexander; Aaron C Ericsson; Jason G Smith; Lillian Maggio-Price
Journal:  Am J Pathol       Date:  2018-05-18       Impact factor: 4.307

Review 5.  Viruses in Rodent Colonies: Lessons Learned from Murine Noroviruses.

Authors:  Stephanie M Karst; Christiane E Wobus
Journal:  Annu Rev Virol       Date:  2015-07-02       Impact factor: 10.431

Review 6.  Histologic Lesions Induced by Murine Norovirus Infection in Laboratory Mice.

Authors:  C C Hsu; S L Piotrowski; S M Meeker; K D Smith; L Maggio-Price; P M Treuting
Journal:  Vet Pathol       Date:  2016-01-20       Impact factor: 2.221

7.  Effects of Murine Norovirus on Chlamydia pneumoniae-Accelerated Atherosclerosis in ApoE(-/-) Mice.

Authors:  Karuna Patil; Lee Ann Campbell; Michael E Rosenfeld; Jisun Paik; Thea Brabb; Kevin D O'brien; Lillian Maggio-Price; Charlie C Hsu
Journal:  Comp Med       Date:  2016       Impact factor: 0.982

Review 8.  Recent advances in understanding noroviruses.

Authors:  Eric Bartnicki; Juliana Bragazzi Cunha; Abimbola O Kolawole; Christiane E Wobus
Journal:  F1000Res       Date:  2017-01-26

9.  Murine norovirus inhibits B cell development in the bone marrow of STAT1-deficient mice.

Authors:  Charlie C Hsu; Stacey M Meeker; Sabine Escobar; Thea L Brabb; Jisun Paik; Heon Park; Brian M Iritani; Lillian Maggio-Price
Journal:  Virology       Date:  2017-12-26       Impact factor: 3.616

10.  Protective role of murine norovirus against Pseudomonas aeruginosa acute pneumonia.

Authors:  Marion Thépaut; Teddy Grandjean; Didier Hober; Pierre-Emmanuel Lobert; Perrine Bortolotti; Karine Faure; Rodrigue Dessein; Eric Kipnis; Benoit Guery
Journal:  Vet Res       Date:  2015-09-04       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.